A Phase I Clinical Study of HMPL-A83 in Patients With Advanced Malignant Neoplasm
NCT05429008
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Tumors
Interventions
DRUG:
HMPL-A83 injection
Sponsor
Hutchmed